Bicyclic nitrogen heterocycles

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544256, A01N 4354, A61K 31505, C07D48700

Patent

active

061503738

ABSTRACT:
Amino-substituted dihydropyrimido[4,5-d]pyrimidinones of the formula in which R.sup.1 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, R.sup.2 represents lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl or lower cycloalkyl-lower alkyl, and R.sup.3 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, heteroaryl, heteroaryl-lower alkyl, lower cycloalkyl, lower cycloalkenyl or lower cycloalkyl-lower alkyl, and pharmaceutically acceptable salts thereof are protein kinase inhibitors. They can be used in the treatment or prophylaxis of inflammatory, immunological, oncological, bronchopulmonary, dermatological and cardiovascular disorders, in the treatment of asthma, central nervous system disorders or diabetic complications or for the prevention of graft rejection following transplant surgery.

REFERENCES:
patent: 5654307 (1997-08-01), Bridges et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Bicyclic nitrogen heterocycles does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bicyclic nitrogen heterocycles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic nitrogen heterocycles will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1257521

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.